Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Investigation of Experimental Factors That Underlie BRCA1/2 mRNA Isoform Expression Variation: Recommendations for Utilizing Targeted RNA Sequencing to Evaluate Potential Spliceogenic Variants.

Lattimore VL, Pearson JF, Currie MJ, Spurdle AB; kConFab Investigators, Robinson BA, Walker LC.

Front Oncol. 2018 May 3;8:140. doi: 10.3389/fonc.2018.00140. eCollection 2018.

2.

Identifying the assembly intermediate in which Gag first associates with unspliced HIV-1 RNA suggests a novel model for HIV-1 RNA packaging.

Barajas BC, Tanaka M, Robinson BA, Phuong DJ, Chutiraka K, Reed JC, Lingappa JR.

PLoS Pathog. 2018 Apr 17;14(4):e1006977. doi: 10.1371/journal.ppat.1006977. eCollection 2018 Apr.

3.

GENDER CONFORMITY, PERCEPTIONS OF SHARED POWER, AND MARITAL QUALITY IN SAME- AND DIFFERENT-SEX MARRIAGES.

Pollitt AM, Robinson BA, Umberson D.

Gend Soc. 2018;32(1):109-131. doi: 10.1177/0891243217742110. Epub 2017 Nov 20.

4.

The Role of Interferon in Persistent Viral Infection: Insights from Murine Norovirus.

Nice TJ, Robinson BA, Van Winkle JA.

Trends Microbiol. 2018 Jun;26(6):510-524. doi: 10.1016/j.tim.2017.10.010. Epub 2017 Nov 17. Review.

5.

Beyond the latch: A new approach to breastfeeding.

Robinson BA, Hartrick Doane G.

Nurse Educ Pract. 2017 Sep;26:115-117. doi: 10.1016/j.nepr.2017.07.011. Epub 2017 Aug 1.

PMID:
28800437
6.

You Can Breathe Easy: IFNλ Handles Flu without Triggering a Damaging Inflammatory Response.

Robinson BA, Nice TJ.

Immunity. 2017 May 16;46(5):768-770. doi: 10.1016/j.immuni.2017.04.027.

7.

Pharmacokinetic and anti-cancer properties of high dose ascorbate in solid tumours of ascorbate-dependent mice.

Campbell EJ, Vissers MCM, Wohlrab C, Hicks KO, Strother RM, Bozonet SM, Robinson BA, Dachs GU.

Free Radic Biol Med. 2016 Oct;99:451-462. doi: 10.1016/j.freeradbiomed.2016.08.027. Epub 2016 Aug 24.

PMID:
27567539
8.

Hypofractionated radiation treatment in early breast cancer: Results in a New Zealand setting.

James ML, Dehn G, Robinson BA.

Asia Pac J Clin Oncol. 2016 Sep;12(3):248-53. doi: 10.1111/ajco.12458. Epub 2016 Mar 9.

PMID:
26956225
9.

SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer.

van Hazel GA, Heinemann V, Sharma NK, Findlay MP, Ricke J, Peeters M, Perez D, Robinson BA, Strickland AH, Ferguson T, Rodríguez J, Kröning H, Wolf I, Ganju V, Walpole E, Boucher E, Tichler T, Shacham-Shmueli E, Powell A, Eliadis P, Isaacs R, Price D, Moeslein F, Taieb J, Bower G, Gebski V, Van Buskirk M, Cade DN, Thurston K, Gibbs P.

J Clin Oncol. 2016 May 20;34(15):1723-31. doi: 10.1200/JCO.2015.66.1181. Epub 2016 Feb 22.

PMID:
26903575
10.

Mutations of Conserved Residues in the Major Homology Region Arrest Assembling HIV-1 Gag as a Membrane-Targeted Intermediate Containing Genomic RNA and Cellular Proteins.

Tanaka M, Robinson BA, Chutiraka K, Geary CD, Reed JC, Lingappa JR.

J Virol. 2015 Dec 9;90(4):1944-63. doi: 10.1128/JVI.02698-15. Print 2016 Feb 15.

11.

Meeting the challenges of interpreting variants of unknown clinical significance in BRCA testing.

Lattimore V, Currie M, Lintott C, Sullivan J, Robinson BA, Walker LC.

N Z Med J. 2015 Aug 7;128(1419):56-61.

PMID:
26365847
12.

A Rhesus Rhadinovirus Viral Interferon (IFN) Regulatory Factor Is Virion Associated and Inhibits the Early IFN Antiviral Response.

Morin G, Robinson BA, Rogers KS, Wong SW.

J Virol. 2015 Aug;89(15):7707-21. doi: 10.1128/JVI.01175-15. Epub 2015 May 13.

13.

Hydrous mineral dehydration around heat-generating nuclear waste in bedded salt formations.

Jordan AB, Boukhalfa H, Caporuscio FA, Robinson BA, Stauffer PH.

Environ Sci Technol. 2015 Jun 2;49(11):6783-90. doi: 10.1021/acs.est.5b01002. Epub 2015 May 22.

PMID:
25965632
14.

Phosphohistone H3 outperforms Ki67 as a marker of outcome for breast cancer patients.

Gerring Z, Pearson JF, Morrin HR, Robinson BA, Harris GC, Walker LC.

Histopathology. 2015 Oct;67(4):538-47. doi: 10.1111/his.12678. Epub 2015 Mar 31.

PMID:
25728258
15.

Cytomegalovirus and Epstein-Barr virus in breast cancer.

Richardson AK, Currie MJ, Robinson BA, Morrin H, Phung Y, Pearson JF, Anderson TP, Potter JD, Walker LC.

PLoS One. 2015 Feb 27;10(2):e0118989. doi: 10.1371/journal.pone.0118989. eCollection 2015. Review.

16.

Social context, parental monitoring, and multisystemic therapy outcomes.

Robinson BA, Winiarski DA, Brennan PA, Foster SL, Cunningham PB, Whitmore EA.

Psychotherapy (Chic). 2015 Mar;52(1):103-110. doi: 10.1037/a0037948. Epub 2014 Nov 3.

17.

Restoring physiological levels of ascorbate slows tumor growth and moderates HIF-1 pathway activity in Gulo(-/-) mice.

Campbell EJ, Vissers MC, Bozonet S, Dyer A, Robinson BA, Dachs GU.

Cancer Med. 2015 Feb;4(2):303-14. doi: 10.1002/cam4.349. Epub 2014 Oct 30.

18.

Hypofractionated radiation treatment following mastectomy in early breast cancer: the Christchurch experience.

Ko DH, Norriss A, Harrington CR, Robinson BA, James ML.

J Med Imaging Radiat Oncol. 2015 Apr;59(2):243-7. doi: 10.1111/1754-9485.12242. Epub 2014 Oct 6.

PMID:
25287654
19.

Dose-intense capecitabine, oxaliplatin and bevacizumab as first line treatment for metastatic, unresectable colorectal cancer: a multi-centre phase II study.

Jackson CG, Sharples K, Thompson PI, O'Donnell A, Robinson BA, Perez DJ, Adams J, Isaacs R, Deva S, Hinder VA, Findlay MP.

BMC Cancer. 2014 Oct 2;14:737. doi: 10.1186/1471-2407-14-737.

20.

How HIV-1 Gag assembles in cells: Putting together pieces of the puzzle.

Lingappa JR, Reed JC, Tanaka M, Chutiraka K, Robinson BA.

Virus Res. 2014 Nov 26;193:89-107. doi: 10.1016/j.virusres.2014.07.001. Epub 2014 Jul 24. Review.

21.

Sustaining a biobank through a series of earthquake swarms: lessons learned from our New Zealand experience.

Morrin HR, Robinson BA.

Biopreserv Biobank. 2013 Aug;11(4):211-5. doi: 10.1089/bio.2013.0033. Epub 2013 Aug 6.

PMID:
24845587
22.

A temporospatial map that defines specific steps at which critical surfaces in the Gag MA and CA domains act during immature HIV-1 capsid assembly in cells.

Robinson BA, Reed JC, Geary CD, Swain JV, Lingappa JR.

J Virol. 2014 May;88(10):5718-41. doi: 10.1128/JVI.03609-13. Epub 2014 Mar 12.

23.

Increased Tumor Ascorbate is Associated with Extended Disease-Free Survival and Decreased Hypoxia-Inducible Factor-1 Activation in Human Colorectal Cancer.

Kuiper C, Dachs GU, Munn D, Currie MJ, Robinson BA, Pearson JF, Vissers MC.

Front Oncol. 2014 Feb 4;4:10. doi: 10.3389/fonc.2014.00010. eCollection 2014.

24.

Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study.

Valle JW, Palmer D, Jackson R, Cox T, Neoptolemos JP, Ghaneh P, Rawcliffe CL, Bassi C, Stocken DD, Cunningham D, O'Reilly D, Goldstein D, Robinson BA, Karapetis C, Scarfe A, Lacaine F, Sand J, Izbicki JR, Mayerle J, Dervenis C, Oláh A, Butturini G, Lind PA, Middleton MR, Anthoney A, Sumpter K, Carter R, Büchler MW.

J Clin Oncol. 2014 Feb 20;32(6):504-12. doi: 10.1200/JCO.2013.50.7657. Epub 2014 Jan 13.

PMID:
24419109
25.

Marginal effects of glucose, insulin and insulin-like growth factor on chemotherapy response in endothelial and colorectal cancer cells.

Volkova E, Robinson BA, Willis J, Currie MJ, Dachs GU.

Oncol Lett. 2014 Feb;7(2):311-320. Epub 2013 Nov 27.

26.

Dual-color fluorescence in situ hybridization reveals an association of chromosome 8q22 but not 8p21 imbalance with high grade invasive breast carcinoma.

Walker LC, McDonald M, Wells JE, Harris GC, Robinson BA, Morris CM.

PLoS One. 2013 Jul 25;8(7):e70790. doi: 10.1371/journal.pone.0070790. Print 2013.

27.

Professional killer cell deficiencies and decreased survival in pulmonary arterial hypertension.

Edwards AL, Gunningham SP, Clare GC, Hayman MW, Smith M, Frampton CM, Robinson BA, Troughton RW, Beckert LE.

Respirology. 2013 Nov;18(8):1271-7. doi: 10.1111/resp.12152.

PMID:
23819819
28.

Pore-scale modeling of multiphase reactive transport with phase transitions and dissolution-precipitation processes in closed systems.

Chen L, Kang Q, Robinson BA, He YL, Tao WQ.

Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Apr;87(4):043306. Epub 2013 Apr 11.

PMID:
23679547
29.

The eroticism of Internet cruising as a self-contained behaviour: a multivariate analysis of men seeking men demographics and getting off online.

Robinson BA, Moskowitz DA.

Cult Health Sex. 2013;15(5):555-69. doi: 10.1080/13691058.2013.774050. Epub 2013 Apr 9.

30.

Consumption of vitamin C is below recommended daily intake in many cancer patients and healthy volunteers in Christchurch.

Dachs GU, Munn DG, Carr AC, Vissers MC, Robinson BA.

N Z Med J. 2014 Mar 7;127(1390):73-6. No abstract available.

PMID:
24670594
31.

Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity.

Currie MJ, Beardsley BE, Harris GC, Gunningham SP, Dachs GU, Dijkstra B, Morrin HR, Wells JE, Robinson BA.

Hum Pathol. 2013 Mar;44(3):402-11. doi: 10.1016/j.humpath.2012.06.004. Epub 2012 Oct 1.

PMID:
23036368
32.

Viral interferon regulatory factors are critical for delay of the host immune response against rhesus macaque rhadinovirus infection.

Robinson BA, O'Connor MA, Li H, Engelmann F, Poland B, Grant R, DeFilippis V, Estep RD, Axthelm MK, Messaoudi I, Wong SW.

J Virol. 2012 Mar;86(5):2769-79. doi: 10.1128/JVI.05657-11. Epub 2011 Dec 14.

33.

Viral interferon regulatory factors decrease the induction of type I and type II interferon during rhesus macaque rhadinovirus infection.

Robinson BA, Estep RD, Messaoudi I, Rogers KS, Wong SW.

J Virol. 2012 Feb;86(4):2197-211. doi: 10.1128/JVI.05047-11. Epub 2011 Dec 7. Erratum in: J Virol. 2012 Apr;86(8):4721.

34.

Characterisation of enzyme prodrug gene therapy combinations in coated spheroids and vascular networks in vitro.

Hunt MA, Li D, Hay MP, Currie MJ, Robinson BA, Patterson AV, Dachs GU.

J Gene Med. 2012 Jan;14(1):62-74. doi: 10.1002/jgm.1635.

PMID:
22147660
35.

Perinatal risk factors in the development of aggression and violence.

LaPrairie JL, Schechter JC, Robinson BA, Brennan PA.

Adv Genet. 2011;75:215-53. doi: 10.1016/B978-0-12-380858-5.00004-6. Review.

PMID:
22078482
36.

Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C.

Price TJ, Zannino D, Wilson K, Simes RJ, Cassidy J, Van Hazel GA, Robinson BA, Broad A, Ganju V, Ackland SP, Tebbutt NC.

Ann Oncol. 2012 Jun;23(6):1531-6. doi: 10.1093/annonc/mdr488. Epub 2011 Oct 29.

PMID:
22039086
37.

Deletion of the monkeypox virus inhibitor of complement enzymes locus impacts the adaptive immune response to monkeypox virus in a nonhuman primate model of infection.

Estep RD, Messaoudi I, O'Connor MA, Li H, Sprague J, Barron A, Engelmann F, Yen B, Powers MF, Jones JM, Robinson BA, Orzechowska BU, Manoharan M, Legasse A, Planer S, Wilk J, Axthelm MK, Wong SW.

J Virol. 2011 Sep;85(18):9527-42. doi: 10.1128/JVI.00199-11. Epub 2011 Jul 13.

38.

Renal transplant recipients have elevated frequencies of circulating myeloid-derived suppressor cells.

Hock BD, Mackenzie KA, Cross NB, Taylor KG, Currie MJ, Robinson BA, Simcock JW, McKenzie JL.

Nephrol Dial Transplant. 2012 Jan;27(1):402-10. doi: 10.1093/ndt/gfr264. Epub 2011 May 26.

PMID:
21617199
39.

Angiogenesis and host immune response contribute to the aggressive character of non-melanoma skin cancers in renal transplant recipients.

Mackenzie KA, Miller AP, Hock BD, Gardner J, Simcock JW, Roake JA, Dachs GU, Robinson BA, Currie MJ.

Histopathology. 2011 May;58(6):875-85. doi: 10.1111/j.1365-2559.2011.03845.x.

PMID:
21585427
40.

Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer.

Volkova E, Willis JA, Wells JE, Robinson BA, Dachs GU, Currie MJ.

Br J Cancer. 2011 Jan 4;104(1):51-9. doi: 10.1038/sj.bjc.6606005. Epub 2010 Nov 16.

41.

Critical role for death-receptor mediated apoptotic signaling in viral myocarditis.

DeBiasi RL, Robinson BA, Leser JS, Brown RD, Long CS, Clarke P.

J Card Fail. 2010 Nov;16(11):901-10. doi: 10.1016/j.cardfail.2010.05.030.

42.

A profile of prognostic and molecular factors in European and Māori breast cancer patients.

Dachs GU, Kano M, Volkova E, Morrin HR, Davey VC, Harris GC, Cheale M, Frampton C, Currie MJ, Wells JE, Robinson BA.

BMC Cancer. 2010 Oct 10;10:543. doi: 10.1186/1471-2407-10-543.

43.

Modeling solute transport through saturated zone ground water at 10 km scale: example from the Yucca Mountain license application.

Kelkar S, Ding M, Chu S, Robinson BA, Arnold B, Meijer A, Eddebbarh AA.

J Contam Hydrol. 2010 Sep 20;117(1-4):7-25. doi: 10.1016/j.jconhyd.2010.05.003. Epub 2010 May 26.

PMID:
20633953
44.
45.

First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients.

Mackenzie KA, Wells JE, Lynn KL, Simcock JW, Robinson BA, Roake JA, Currie MJ.

Nephrol Dial Transplant. 2010 Jan;25(1):300-6. doi: 10.1093/ndt/gfp482. Epub 2009 Sep 25.

PMID:
19783601
46.

Inhibitors of HIV-1 attachment. Part 4: A study of the effect of piperazine substitution patterns on antiviral potency in the context of indole-based derivatives.

Wang T, Kadow JF, Zhang Z, Yin Z, Gao Q, Wu D, Parker DD, Yang Z, Zadjura L, Robinson BA, Gong YF, Spicer TP, Blair WS, Shi PY, Yamanaka G, Lin PF, Meanwell NA.

Bioorg Med Chem Lett. 2009 Sep 1;19(17):5140-5. doi: 10.1016/j.bmcl.2009.07.076. Epub 2009 Jul 18. Erratum in: Bioorg Med Chem Lett. 2010 Feb 15;20(4):1462. Spicer, Timothy P [added].

PMID:
19664921
47.

Cardiac cell-specific apoptotic and cytokine responses to reovirus infection: determinants of myocarditic phenotype.

Miyamoto SD, Brown RD, Robinson BA, Tyler KL, Long CS, Debiasi RL.

J Card Fail. 2009 Aug;15(6):529-39. doi: 10.1016/j.cardfail.2009.01.004. Epub 2009 Mar 3.

48.

Inhibitors of HIV-1 attachment. Part 3: A preliminary survey of the effect of structural variation of the benzamide moiety on antiviral activity.

Meanwell NA, Wallace OB, Wang H, Deshpande M, Pearce BC, Trehan A, Yeung KS, Qiu Z, Wright JJ, Robinson BA, Gong YF, Wang HG, Spicer TP, Blair WS, Shi PY, Lin PF.

Bioorg Med Chem Lett. 2009 Sep 1;19(17):5136-9. doi: 10.1016/j.bmcl.2009.07.027. Epub 2009 Jul 10. Erratum in: Bioorg Med Chem Lett. 2010 Feb 15;20(4):1461. Spicer, Timothy P [added].

PMID:
19632112
49.

Inhibitors of HIV-1 attachment. Part 2: An initial survey of indole substitution patterns.

Meanwell NA, Wallace OB, Fang H, Wang H, Deshpande M, Wang T, Yin Z, Zhang Z, Pearce BC, James J, Yeung KS, Qiu Z, Kim Wright JJ, Yang Z, Zadjura L, Tweedie DL, Yeola S, Zhao F, Ranadive S, Robinson BA, Gong YF, Wang HG, Spicer TP, Blair WS, Shi PY, Colonno RJ, Lin PF.

Bioorg Med Chem Lett. 2009 Apr 1;19(7):1977-81. doi: 10.1016/j.bmcl.2009.02.040. Epub 2009 Feb 13. Erratum in: Bioorg Med Chem Lett. 2010 Feb 15;20(4):1460. Spicer, Timothy P [added].

PMID:
19251416
50.

Audit of anticoagulant thromboprophylaxis in hospitalized oncology patients.

Chin PK, Beckert LE, Gunningham S, Edwards AL, Robinson BA.

Intern Med J. 2009 Dec;39(12):819-25. doi: 10.1111/j.1445-5994.2008.01828.x. Epub 2008 Nov 3.

PMID:
19220527

Supplemental Content

Loading ...
Support Center